Clinical Trial Update: Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating tiragolumab in combination with atezolizumab and bevacizumab for previously treated advanced non-squamous non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Georgetown University | Conditions: Non-squamous Non-small-cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING